|Surgery alone versus chemoradiotherapy followed by surgery for resectable cancer of the oesophagus: a randomised controlled phase III trial|
BH Burmeister, BM Smithers, V Gebski, L Fitzgerald, RJ Simes, P Devitt, ...
The lancet oncology 6 (9), 659-668, 2005
|Escalated-dose versus standard-dose conformal radiotherapy in prostate cancer: first results from the MRC RT01 randomised controlled trial|
DP Dearnaley, MR Sydes, JD Graham, EG Aird, D Bottomley, RA Cowan, ...
The lancet oncology 8 (6), 475-487, 2007
|Comparative analysis of prostate‐specific antigen free survival outcomes for patients with low, intermediate and high risk prostate cancer treatment by radical therapy. Results …|
P Grimm, I Billiet, D Bostwick, AP Dicker, S Frank, J Immerzeel, M Keyes, ...
BJU international 109, 22-29, 2012
|Activation of thymic regeneration in mice and humans following androgen blockade|
JS Sutherland, GL Goldberg, MV Hammett, AP Uldrich, SP Berzins, ...
The Journal of Immunology 175 (4), 2741-2753, 2005
|Escalated-dose versus control-dose conformal radiotherapy for prostate cancer: long-term results from the MRC RT01 randomised controlled trial|
DP Dearnaley, G Jovic, I Syndikus, V Khoo, RA Cowan, JD Graham, ...
The lancet oncology 15 (4), 464-473, 2014
|15-Year biochemical relapse free survival in clinical Stage T1-T3 prostate cancer following combined external beam radiotherapy and brachytherapy; Seattle experience|
JE Sylvester, PD Grimm, JC Blasko, J Millar, PF Orio, S Skoglund, ...
International Journal of Radiation Oncology* Biology* Physics 67 (1), 57-64, 2007
|Timing of androgen-deprivation therapy in patients with prostate cancer with a rising PSA (TROG 03.06 and VCOG PR 01-03 [TOAD]): a randomised, multicentre, non-blinded, phase 3 …|
GM Duchesne, HH Woo, JK Bassett, SJ Bowe, C D'Este, M Frydenberg, ...
The Lancet Oncology 17 (6), 727-737, 2016
|Post-prostatectomy radiation therapy: consensus guidelines of the Australian and New Zealand Radiation Oncology Genito-urinary group|
MA Sidhom, AB Kneebone, M Lehman, KL Wiltshire, JL Millar, ...
Radiotherapy and Oncology 88 (1), 10-19, 2008
|Human immunodeficiency virus–related primary central nervous system lymphoma: Factors influencing survival in 111 patients|
ME Newell, JF Hoy, SG Cooper, B DeGraaff, AE Grulich, M Bryant, ...
Cancer 100 (12), 2627-2636, 2004
|AP hase III trial to investigate the timing of radiotherapy for prostate cancer with high‐risk features: background and rationale of the Radiotherapy–Adjuvant Versus Early …|
M Pearse, C Fraser‐Browne, ID Davis, GM Duchesne, R Fisher, ...
BJU international 113, 7-12, 2014
|In vivo characterization and numerical simulation of prostate properties for non‐thermal irreversible electroporation ablation|
RE Neal, JL Millar, H Kavnoudias, P Royce, F Rosenfeldt, A Pham, ...
The Prostate 74 (5), 458-468, 2014
|The current use of active surveillance in an Australian cohort of men: a pattern of care analysis from the Victorian Prostate Cancer Registry|
M Weerakoon, N Papa, N Lawrentschuk, S Evans, J Millar, M Frydenberg, ...
BJU Int 115 (Suppl 5), 50-6, 2015
|A randomized phase III trial of preoperative chemoradiation followed by surgery (CR-S) versus surgery alone (S) for localized respectable cancer of the esophagus|
Prog Proc Am Soc Clin Oncol 21, 130a, 2002
|Patterns of care for men diagnosed with prostate cancer in Victoria from 2008 to 2011|
SM Evans, JL Millar, ID Davis, DG Murphy, DM Bolton, GG Giles, ...
Medical journal of Australia 198 (10), 540-545, 2013
|High-dose-rate brachytherapy in combination with conformal external beam radiotherapy in the treatment of prostate cancer|
DR Zwahlen, N Andrianopoulos, B Matheson, GM Duchesne, JL Millar
Brachytherapy 9 (1), 27-35, 2010
|Urethral strictures following high-dose-rate brachytherapy for prostate cancer: analysis of risk factors|
BR Hindson, JL Millar, B Matheson
Brachytherapy 12 (1), 50-55, 2013
|Effect of intensity-modulated pelvic radiotherapy on second cancer risk in the postoperative treatment of endometrial and cervical cancer|
DR Zwahlen, JD Ruben, P Jones, F Gagliardi, JL Millar, U Schneider
International Journal of Radiation Oncology* Biology* Physics 74 (2), 539-545, 2009
|Factors predicting for urinary morbidity following 125iodine transperineal prostate brachytherapy|
SG Williams, JL Millar, GM Duchesne, MJ Dally, PL Royce, RM Snow
Radiotherapy and oncology 73 (1), 33-38, 2004
|Phase II clinical trial of preoperative combined chemoradiation for T3 and T4 resectable rectal cancer|
JJ Tjandra, DM Reading, SA McLachlan, IF Gunn, MD Green, ...
Diseases of the colon & rectum 44 (8), 1113-1122, 2001
|Adjuvant radiotherapy versus early salvage radiotherapy following radical prostatectomy (TROG 08.03/ANZUP RAVES): a randomised, controlled, phase 3, non-inferiority trial|
A Kneebone, C Fraser-Browne, GM Duchesne, R Fisher, M Frydenberg, ...
The Lancet Oncology 21 (10), 1331-1340, 2020